BDO Wealth Advisors’s Recursion Pharmaceuticals RXRX Stock Holding History

BDO Wealth Advisors’s Portfolio RXRX Stock Details RXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$45.4K	Hold	6,082	–	–	0.01%	448
2023 Q1	$40.6K	Hold	6,082	–	–	0.01%	455
2022 Q4	$46.9K	Hold	6,082	–	–	0.01%	421
2022 Q3	$65K	Hold	6,082	–	–	0.01%	374
2022 Q2	$50K	Hold	6,082	–	–	0.01%	409
2022 Q1	$44K	Hold	6,082	–	–	﹤0.01%	454
2021 Q4	$104K	Buy	+6,082	New	+$114K	0.01%	347

Other funds holding RXRX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return

MCMU

MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return

DCI

Data Collective IV Palo Alto, California $55.9M AUM 49.14% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

BDO Wealth Advisors's RXRX Position: Q2 2023 in Review

BDO Wealth Advisors held its Recursion Pharmaceuticals (RXRX) position steady in Q2 2023 at 6,082 shares worth $45.4K. The position accounts for 0.01% of the portfolio, ranked #448.

BDO Wealth Advisors first reported a position in RXRX in Q4 2021 and has held it in 7 quarters since. The position peaked at $104K in Q4 2021. 158 funds tracked by Wall St. Rank hold RXRX as of Q2 2023.

BDO Wealth Advisors held 6,082 shares of Recursion Pharmaceuticals worth $45.4K as of Q2 2023.
BDO Wealth Advisors left its Recursion Pharmaceuticals share count unchanged in Q2 2023.
Recursion Pharmaceuticals made up 0.01% of BDO Wealth Advisors's portfolio in Q2 2023, its #448 holding.
BDO Wealth Advisors first reported a position in Recursion Pharmaceuticals in Q4 2021 and has held it in 7 quarters since.
BDO Wealth Advisors's Recursion Pharmaceuticals position peaked at $104K in Q4 2021.
158 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2023.

Based on BDO Wealth Advisors's 13F filing for Q2 2023, filed 1 Aug 2023.